Cell to Cure ApS
Private limited companyCVR 39401975BirkerødActive
Cell to Cure ApS is a private limited company, based in Birkerød, active in research and experimental development on natural sciences and engineering, founded in 2018. Equity was negative at the end of 2025 (−DKK 1.2m). The company made a loss in both 2024 and 2025, most recently DKK 9.8m. Operations are spread over 4 production units in 4 towns.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 7m to DKK 9.8m (2024 → 2025).
- Equity turned negative: −DKK 1.2m (2024 → 2025).
Employees
- 7 fewer employees than a year earlier: 5 (07/2026) against 12 (07/2025).
Registrations, last 24 months
- 07/07/2025: Name changed from Cell2Cure ApS to Cell to Cure ApS
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 523 | 295 | 389 | 100 | −2,803 | −3,076 | −9.8% |
| Operating profit (EBIT) | – | – | −658 | −1,821 | −9,187 | −12,503 | −36.1% |
| Profit before tax | 517 | 280 | −672 | −1,931 | −9,240 | −12,709 | −37.5% |
| Net profit | 405 | 218 | −402 | −1,534 | −6,987 | −9,793 | −40.2% |
| Total assets | 839 | 1,014 | 1,487 | 1,871 | 6,080 | 9,578 | +57.5% |
| Equity | 462 | 695 | −366 | −1,899 | 3,114 | −1,179 | −137.9% |
| Liabilities | – | – | 1,853 | 3,746 | 2,966 | 10,757 | +262.6% |
| Cash and cash equivalents | 815 | 463 | 602 | 273 | 962 | 193 | −80% |
| Average number of employees | 0 | 0 | 5 | 5 | 7 | 12 | +71.4% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 1.2m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 4 years in a row
Net result has been negative in 2022–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 22/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/09/2023 – 31/12/2024 | 19/05/2025 | The company | PDFXBRL |
| 2023 | 01/09/2022 – 31/08/2023 | 17/11/2023 | The company | PDFXBRL |
| 2022 | 01/09/2021 – 31/08/2022 | 01/03/2023 | The company | PDFXBRL |
| 2021 | 01/09/2020 – 31/08/2021 | 26/11/2021 | The company | PDFXBRL |
| 2020 | 01/09/2019 – 31/08/2020 | 06/11/2020 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,379of 69,742 Better than 1% | No. 67,455of 69,964 Better than 4% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 281of 323 Better than 13% | No. 257of 329 Better than 22% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,366of 33,588 Better than 1% | No. 32,047of 33,687 Better than 5% |
| All companies of type ApS66,508 companies in the comparison | No. 66,074of 66,379 Better than 0% | No. 63,971of 66,505 Better than 4% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Cell to Cure ApS−DKK 3.1m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Cell to Cure ApS−DKK 9.8m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Cell to Cure ApS−DKK 1.2m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Cell to Cure ApS5
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Medic Advice ApS5%
- Endeavour Cells ApS50%
- Ekblond.ApS10%
- JKastrup.ApS10%
- Lmn.aps10%
Management
9 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Annette Ekblond | Director | 07/03/2018 |
| Jens Kastrup | CEO | 07/03/2018 |
| Mandana Haack-Sørensen | Director | 07/03/2018 |
| Martin Roland Jensen | Director | 11/03/2022 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Annette Ekblond | Board member | 13/12/2022 |
| Jens Kastrup | Board member | 13/12/2022 |
| Mandana Haack-Sørensen | Board member | 13/12/2022 |
| Anders Østergaard | Chair of the board | 05/01/2024 |
| Martin Roland Jensen | Board member | 05/01/2024 |
- Founders
- Ekblond.ApS, JKastrup.ApS, Lmn.aps
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Martin Roland Jensen | Chair of the board | 13/12/2022 | 04/01/2024 |
| Jesper Kihl | Board member | 13/12/2022 | 12/01/2024 |
Signing rule: Selskabet tegnes af den samlede bestyrelse i forening eller af bestyrelsesformanden i forening med enten ét andet bestyrelsesmedlem eller én direktør
Address and production units
4 active production unitsKajerødgård 9
3460 Birkerød
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Cell to Cure ApS | Kajerødgård 9, 3460 Birkerød | 4 | 1023424734 |
| Cell to Cure Clinic | Dronningensgade 97C, 1, 7000 Fredericia | 2 | 1032051886 |
| Cell to Cure ApS | Rønnegade 2, 4, 2100 København Ø | – | 1032092868 |
| Cell to Cure ApS | Transformervej 8, 2860 Søborg | – | 1029259441 |
Purpose
Selskabets formål er at drive virksomhed med handel, rådgivning og assistance inden for farmaceutisk og bioteknologisk industri og beslægtede brancher, samt anden dermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
48 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20253 changesname 1 · accounts 1 · industry 1
- NameName changed from Cell2Cure ApS to Cell to Cure ApS
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202414 changesmanagement 4 · capital 1 · ownership 9
- ManagementJesper Kihl stepped down as board member
- ManagementMartin Roland Jensen appointed board member
- ManagementAnders Østergaard appointed chair of the board
- ManagementMartin Roland Jensen stepped down as chair of the board
- CapitalShare capital changed from 58,941 DKK to 120,288 DKK
- OwnershipEkblond.ApS registered as owner (10%)
- OwnershipMEDIC ADVICE ApS registered as owner (5%)
- OwnershipEndeavour Cells ApS registered as owner (50%)
- OwnershipJKastrup.ApS registered as owner (10%)
- OwnershipLMN.ApS registered as owner (10%)
- OwnershipMEDIC ADVICE ApS is no longer registered as owner
- OwnershipLMN.ApS is no longer registered as owner
- OwnershipEkblond.ApS is no longer registered as owner
- OwnershipJKastrup.ApS is no longer registered as owner
20232 changesaccounts 2
- AccountsAnnual report for 2023 published
- AccountsAnnual report for 2022 published
20227 changesmanagement 6 · capital 1
- ManagementMartin Roland Jensen appointed chair of the board
- ManagementJesper Kihl appointed board member
- ManagementAnnette Ekblond appointed board member
- ManagementJens Kastrup appointed board member
- ManagementMandana Haack-Sørensen appointed board member
- CapitalShare capital changed from 56,873 DKK to 58,941 DKK
- ManagementMartin Roland Jensen appointed director
20214 changesaccounts 1 · capital 1 · ownership 2
- AccountsAnnual report for 2021 published
- CapitalShare capital changed from 54,805 DKK to 56,873 DKK
- OwnershipMEDIC ADVICE ApS registered as owner (10%)
- OwnershipMEDIC ADVICE ApS is no longer registered as owner
20202 changesaccounts 1 · capital 1
- AccountsAnnual report for 2020 published
- CapitalShare capital changed from 52,737 DKK to 54,805 DKK
20198 changescapital 1 · ownership 7
- CapitalShare capital changed from 50,100 DKK to 52,737 DKK
- OwnershipLMN.ApS registered as owner (25%)
- OwnershipMEDIC ADVICE ApS registered as owner (5%)
- OwnershipEkblond.ApS registered as owner (25%)
- OwnershipJKastrup.ApS registered as owner (25%)
- OwnershipEkblond.ApS is no longer registered as owner
- OwnershipLMN.ApS is no longer registered as owner
- OwnershipJKastrup.ApS is no longer registered as owner
20187 changesfounded 1 · management 3 · ownership 3
- FoundedRegistered as Cell2Cure ApS
- ManagementJens Kastrup appointed ceo
- ManagementMandana Haack-Sørensen appointed director
- ManagementAnnette Ekblond appointed director
- OwnershipEkblond.ApS registered as owner (33.33%)
- OwnershipLMN.ApS registered as owner (33.33%)
- OwnershipJKastrup.ApS registered as owner (33.33%)
Related companies
Same industry in Rudersdal
- Dhi A/S345 employees
- Bioneer A/S82 employees
- Dansk Fundamental Metrologi A/S55 employees
- Glycom A/S51 employees
- Evaxion A/S46 employees
- Presto Engineering Denmark ApS39 employees
Same people in management
- Monjasa A/Svia Anders Østergaard
- Monjasa Holding A/Svia Anders Østergaard
- AHA Livestage ApSvia Anders Østergaard
- Expres2ion Biotechnologies ApSvia Martin Roland Jensen
- AdaptVac ApSvia Martin Roland Jensen
- C-bed Holding A/Svia Anders Østergaard
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.